Skip to main content
Veterinary Medicines

PERCRISON 200 Premix, 200 mg/g Premiscela per alimenti medicamentosi. Per suini, polli da carne, ovaiole, pesci.

Authorised
  • Chlortetracycline

Product identification

Medicine name:
PERCRISON 200 Premix, 200 mg/g Premiscela per alimenti medicamentosi. Per suini, polli da carne, ovaiole, pesci.
Active substance:
  • Chlortetracycline
Target species:
  • Pig
  • Chicken (broiler)
  • Chicken (layer hen)
  • Fish
Route of administration:
  • In-feed use

Product details

Active substance and strength:
  • Chlortetracycline
    200.00
    milligram(s)
    /
    1.00
    gram(s)
Pharmaceutical form:
  • Premix for medicated feeding stuff
Withdrawal period by route of administration:
  • In-feed use
    • Pig
      • Meat and offal
        7
        day
    • Chicken (broiler)
      • Meat and offal
        6
        day
    • Chicken (layer hen)
      • Egg
        9
        day
    • Fish
      • Meat and offal
        500
        degree day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01AA03
Authorisation status:
  • Valid
Authorised in:
  • Italy
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Ceva Salute Animale S.p.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Ceva Salute Animale S.p.A.
  • Unione Commerciale Lombarda S.p.A.
Responsible authority:
  • MdS
Authorisation number:
This information is not available for this product.
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Italian (PDF)
Published on: 23/11/2022
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."